nodes	percent_of_prediction	percent_of_DWPC	metapath
Norepinephrine—POU5F1—cerebellum—brain cancer	0.0309	0.0665	CbGeAlD
Norepinephrine—SLC18A2—telencephalic ventricle—brain cancer	0.0274	0.0589	CbGeAlD
Norepinephrine—Gangrene—Hydroxyurea—brain cancer	0.0193	0.24	CcSEcCtD
Norepinephrine—SLC18A2—ganglion—brain cancer	0.0171	0.0367	CbGeAlD
Norepinephrine—DRD2—telencephalic ventricle—brain cancer	0.0153	0.0328	CbGeAlD
Norepinephrine—SLC18A1—endocrine gland—brain cancer	0.013	0.0279	CbGeAlD
Norepinephrine—SLC18A1—head—brain cancer	0.0128	0.0276	CbGeAlD
Norepinephrine—SLC22A1—ganglion—brain cancer	0.0127	0.0273	CbGeAlD
Norepinephrine—SLC18A1—central nervous system—brain cancer	0.0117	0.0252	CbGeAlD
Norepinephrine—Extravasation—Carboplatin—brain cancer	0.0112	0.14	CcSEcCtD
Norepinephrine—SLC6A2—ganglion—brain cancer	0.0104	0.0224	CbGeAlD
Norepinephrine—DRD2—ganglion—brain cancer	0.00949	0.0204	CbGeAlD
Norepinephrine—PAH—endocrine gland—brain cancer	0.00933	0.0201	CbGeAlD
Norepinephrine—SLC18A1—brain—brain cancer	0.0093	0.02	CbGeAlD
Norepinephrine—PAH—head—brain cancer	0.00921	0.0198	CbGeAlD
Norepinephrine—PAH—central nervous system—brain cancer	0.00841	0.0181	CbGeAlD
Norepinephrine—SLC18A2—brainstem—brain cancer	0.00742	0.0159	CbGeAlD
Norepinephrine—ADRA1A—hindbrain—brain cancer	0.00735	0.0158	CbGeAlD
Norepinephrine—DRD2—hindbrain—brain cancer	0.0072	0.0155	CbGeAlD
Norepinephrine—PAH—brain—brain cancer	0.00668	0.0143	CbGeAlD
Norepinephrine—SLC18A2—telencephalon—brain cancer	0.00659	0.0142	CbGeAlD
Norepinephrine—ADRA1D—telencephalon—brain cancer	0.00651	0.014	CbGeAlD
Norepinephrine—SLC18A2—medulla oblongata—brain cancer	0.00517	0.0111	CbGeAlD
Norepinephrine—Photophobia—Procarbazine—brain cancer	0.0051	0.0635	CcSEcCtD
Norepinephrine—SLC22A1—telencephalon—brain cancer	0.00491	0.0105	CbGeAlD
Norepinephrine—SLC18A2—midbrain—brain cancer	0.00473	0.0102	CbGeAlD
Norepinephrine—ADRB1—telencephalon—brain cancer	0.00473	0.0102	CbGeAlD
Norepinephrine—SLC6A2—brainstem—brain cancer	0.00453	0.00973	CbGeAlD
Norepinephrine—ADRA1A—brainstem—brain cancer	0.00421	0.00905	CbGeAlD
Norepinephrine—SLC18A2—endocrine gland—brain cancer	0.00415	0.00893	CbGeAlD
Norepinephrine—ADRA1B—head—brain cancer	0.00414	0.0089	CbGeAlD
Norepinephrine—DRD2—brainstem—brain cancer	0.00413	0.00887	CbGeAlD
Norepinephrine—ADRA1D—endocrine gland—brain cancer	0.0041	0.00882	CbGeAlD
Norepinephrine—SLC18A2—head—brain cancer	0.0041	0.00881	CbGeAlD
Norepinephrine—ADRA1D—head—brain cancer	0.00405	0.0087	CbGeAlD
Norepinephrine—SLC6A2—telencephalon—brain cancer	0.00402	0.00864	CbGeAlD
Norepinephrine—SLC22A3—gonad—brain cancer	0.00391	0.00841	CbGeAlD
Norepinephrine—Extravasation—Carmustine—brain cancer	0.0039	0.0485	CcSEcCtD
Norepinephrine—ADRA1B—central nervous system—brain cancer	0.00378	0.00812	CbGeAlD
Norepinephrine—SLC18A2—central nervous system—brain cancer	0.00374	0.00804	CbGeAlD
Norepinephrine—ADRA1A—telencephalon—brain cancer	0.00374	0.00803	CbGeAlD
Norepinephrine—ADRA1D—central nervous system—brain cancer	0.0037	0.00795	CbGeAlD
Norepinephrine—DRD2—telencephalon—brain cancer	0.00366	0.00787	CbGeAlD
Norepinephrine—SLC18A2—cerebellum—brain cancer	0.00366	0.00786	CbGeAlD
Norepinephrine—ADRA2C—telencephalon—brain cancer	0.00356	0.00765	CbGeAlD
Norepinephrine—SLC6A2—gonad—brain cancer	0.00335	0.00721	CbGeAlD
Norepinephrine—SLC6A2—medulla oblongata—brain cancer	0.00316	0.00679	CbGeAlD
Norepinephrine—SLC22A1—endocrine gland—brain cancer	0.0031	0.00665	CbGeAlD
Norepinephrine—SLC22A1—head—brain cancer	0.00306	0.00657	CbGeAlD
Norepinephrine—Extravasation—Etoposide—brain cancer	0.00301	0.0375	CcSEcCtD
Norepinephrine—ADRA1B—brain—brain cancer	0.003	0.00645	CbGeAlD
Norepinephrine—DRD2—pituitary gland—brain cancer	0.00298	0.00641	CbGeAlD
Norepinephrine—ADRB1—endocrine gland—brain cancer	0.00298	0.0064	CbGeAlD
Norepinephrine—SLC18A2—brain—brain cancer	0.00297	0.00639	CbGeAlD
Norepinephrine—SLC22A3—endocrine gland—brain cancer	0.00296	0.00636	CbGeAlD
Norepinephrine—ADRB1—head—brain cancer	0.00294	0.00632	CbGeAlD
Norepinephrine—ADRA1D—brain—brain cancer	0.00294	0.00631	CbGeAlD
Norepinephrine—SLC22A3—head—brain cancer	0.00292	0.00628	CbGeAlD
Norepinephrine—Sweating—Procarbazine—brain cancer	0.00292	0.0363	CcSEcCtD
Norepinephrine—ADRA2C—pituitary gland—brain cancer	0.0029	0.00623	CbGeAlD
Norepinephrine—ADRA2A—telencephalon—brain cancer	0.00284	0.0061	CbGeAlD
Norepinephrine—ADRA2C—medulla oblongata—brain cancer	0.0028	0.00601	CbGeAlD
Norepinephrine—SLC22A1—central nervous system—brain cancer	0.00279	0.00599	CbGeAlD
Norepinephrine—SLC22A5—pituitary gland—brain cancer	0.00278	0.00597	CbGeAlD
Norepinephrine—Dopamine—CYP2C9—brain cancer	0.00276	0.506	CrCbGaD
Norepinephrine—Epinephrine—CYP2C9—brain cancer	0.0027	0.494	CrCbGaD
Norepinephrine—ADRB1—central nervous system—brain cancer	0.00269	0.00577	CbGeAlD
Norepinephrine—SLC22A5—medulla oblongata—brain cancer	0.00268	0.00576	CbGeAlD
Norepinephrine—SLC22A3—central nervous system—brain cancer	0.00267	0.00573	CbGeAlD
Norepinephrine—DRD2—midbrain—brain cancer	0.00263	0.00565	CbGeAlD
Norepinephrine—ADRA2C—midbrain—brain cancer	0.00256	0.00549	CbGeAlD
Norepinephrine—SLC6A2—endocrine gland—brain cancer	0.00254	0.00545	CbGeAlD
Norepinephrine—SLC6A2—head—brain cancer	0.0025	0.00538	CbGeAlD
Norepinephrine—ADRA2C—spinal cord—brain cancer	0.00249	0.00536	CbGeAlD
Norepinephrine—SLC22A5—midbrain—brain cancer	0.00245	0.00526	CbGeAlD
Norepinephrine—Arrhythmia—Procarbazine—brain cancer	0.00244	0.0303	CcSEcCtD
Norepinephrine—SLC22A5—spinal cord—brain cancer	0.00239	0.00513	CbGeAlD
Norepinephrine—ADRA2A—gonad—brain cancer	0.00237	0.00509	CbGeAlD
Norepinephrine—ADRA1A—endocrine gland—brain cancer	0.00236	0.00506	CbGeAlD
Norepinephrine—ADRA1A—head—brain cancer	0.00233	0.005	CbGeAlD
Norepinephrine—ADRA2A—pituitary gland—brain cancer	0.00231	0.00497	CbGeAlD
Norepinephrine—DRD2—endocrine gland—brain cancer	0.00231	0.00496	CbGeAlD
Norepinephrine—SLC6A2—central nervous system—brain cancer	0.00228	0.00491	CbGeAlD
Norepinephrine—DRD2—head—brain cancer	0.00228	0.0049	CbGeAlD
Norepinephrine—ADRA2A—medulla oblongata—brain cancer	0.00223	0.0048	CbGeAlD
Norepinephrine—ADRA2C—head—brain cancer	0.00222	0.00476	CbGeAlD
Norepinephrine—SLC22A1—brain—brain cancer	0.00221	0.00476	CbGeAlD
Norepinephrine—ADRB1—brain—brain cancer	0.00213	0.00458	CbGeAlD
Norepinephrine—ADRA1A—central nervous system—brain cancer	0.00212	0.00456	CbGeAlD
Norepinephrine—SLC22A3—brain—brain cancer	0.00212	0.00455	CbGeAlD
Norepinephrine—DRD2—central nervous system—brain cancer	0.00208	0.00447	CbGeAlD
Norepinephrine—ADRA1A—cerebellum—brain cancer	0.00208	0.00446	CbGeAlD
Norepinephrine—Hypertension—Procarbazine—brain cancer	0.00205	0.0255	CcSEcCtD
Norepinephrine—ADRA2A—midbrain—brain cancer	0.00204	0.00438	CbGeAlD
Norepinephrine—DRD2—cerebellum—brain cancer	0.00203	0.00437	CbGeAlD
Norepinephrine—ADRA2C—central nervous system—brain cancer	0.00202	0.00435	CbGeAlD
Norepinephrine—Anxiety—Procarbazine—brain cancer	0.00202	0.0251	CcSEcCtD
Norepinephrine—ADRA2A—spinal cord—brain cancer	0.00199	0.00428	CbGeAlD
Norepinephrine—ADRA2C—cerebellum—brain cancer	0.00198	0.00425	CbGeAlD
Norepinephrine—CYP1A2—endocrine gland—brain cancer	0.00195	0.00419	CbGeAlD
Norepinephrine—Vomiting—Lomustine—brain cancer	0.00194	0.0242	CcSEcCtD
Norepinephrine—SLC22A5—cerebellum—brain cancer	0.00189	0.00407	CbGeAlD
Norepinephrine—Hyperhidrosis—Procarbazine—brain cancer	0.00187	0.0233	CcSEcCtD
Norepinephrine—SLC6A2—brain—brain cancer	0.00181	0.0039	CbGeAlD
Norepinephrine—ADRA2A—endocrine gland—brain cancer	0.00179	0.00385	CbGeAlD
Norepinephrine—ADRA2A—head—brain cancer	0.00177	0.0038	CbGeAlD
Norepinephrine—ADRA1A—brain—brain cancer	0.00169	0.00362	CbGeAlD
Norepinephrine—DRD2—brain—brain cancer	0.00165	0.00355	CbGeAlD
Norepinephrine—ADRA2A—central nervous system—brain cancer	0.00161	0.00347	CbGeAlD
Norepinephrine—ADRA2C—brain—brain cancer	0.00161	0.00345	CbGeAlD
Norepinephrine—ADRA2A—cerebellum—brain cancer	0.00158	0.00339	CbGeAlD
Norepinephrine—SLC22A5—brain—brain cancer	0.00154	0.00331	CbGeAlD
Norepinephrine—Arrhythmia—Carmustine—brain cancer	0.00153	0.019	CcSEcCtD
Norepinephrine—Dyspnoea—Hydroxyurea—brain cancer	0.00134	0.0166	CcSEcCtD
Norepinephrine—Hypertension—Carmustine—brain cancer	0.00128	0.016	CcSEcCtD
Norepinephrine—ADRA2A—brain—brain cancer	0.00128	0.00275	CbGeAlD
Norepinephrine—Chest pain—Carmustine—brain cancer	0.00127	0.0157	CcSEcCtD
Norepinephrine—Anxiety—Carmustine—brain cancer	0.00126	0.0157	CcSEcCtD
Norepinephrine—Hypertension—Temozolomide—brain cancer	0.00124	0.0154	CcSEcCtD
Norepinephrine—Vomiting—Procarbazine—brain cancer	0.00123	0.0153	CcSEcCtD
Norepinephrine—Anxiety—Temozolomide—brain cancer	0.00122	0.0152	CcSEcCtD
Norepinephrine—Headache—Procarbazine—brain cancer	0.00122	0.0151	CcSEcCtD
Norepinephrine—Hyperhidrosis—Temozolomide—brain cancer	0.00113	0.0141	CcSEcCtD
Norepinephrine—Dyspnoea—Carmustine—brain cancer	0.00108	0.0135	CcSEcCtD
Norepinephrine—Dyspnoea—Temozolomide—brain cancer	0.00105	0.013	CcSEcCtD
Norepinephrine—Hypertension—Etoposide—brain cancer	0.000993	0.0123	CcSEcCtD
Norepinephrine—Chest pain—Etoposide—brain cancer	0.000979	0.0122	CcSEcCtD
Norepinephrine—Vomiting—Hydroxyurea—brain cancer	0.000954	0.0119	CcSEcCtD
Norepinephrine—Headache—Hydroxyurea—brain cancer	0.00094	0.0117	CcSEcCtD
Norepinephrine—Hyperhidrosis—Etoposide—brain cancer	0.000907	0.0113	CcSEcCtD
Norepinephrine—Dyspnoea—Etoposide—brain cancer	0.000837	0.0104	CcSEcCtD
Norepinephrine—Vomiting—Carmustine—brain cancer	0.000772	0.0096	CcSEcCtD
Norepinephrine—Headache—Carmustine—brain cancer	0.00076	0.00945	CcSEcCtD
Norepinephrine—Vomiting—Temozolomide—brain cancer	0.000746	0.00927	CcSEcCtD
Norepinephrine—Headache—Temozolomide—brain cancer	0.000735	0.00914	CcSEcCtD
Norepinephrine—Vomiting—Etoposide—brain cancer	0.000597	0.00742	CcSEcCtD
Norepinephrine—Headache—Etoposide—brain cancer	0.000588	0.00731	CcSEcCtD
Norepinephrine—ADRA1B—Signaling Pathways—SMO—brain cancer	0.000108	0.000241	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—CYP2C9—brain cancer	0.000107	0.000239	CbGpPWpGaD
Norepinephrine—ADRB1—GPCR downstream signaling—PIK3CG—brain cancer	0.000107	0.000238	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling by GPCR—PIK3CG—brain cancer	0.000107	0.000237	CbGpPWpGaD
Norepinephrine—ADRA2B—GPCR downstream signaling—PIK3CG—brain cancer	0.000106	0.000236	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—SHH—brain cancer	0.000105	0.000234	CbGpPWpGaD
Norepinephrine—ADRB2—GPCR downstream signaling—PIK3CG—brain cancer	0.000105	0.000233	CbGpPWpGaD
Norepinephrine—SLC22A3—Metabolism—PIK3CG—brain cancer	0.000104	0.000232	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—NOTCH2—brain cancer	0.000104	0.000232	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—TRPC6—brain cancer	0.000101	0.000226	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—SHH—brain cancer	0.000101	0.000225	CbGpPWpGaD
Norepinephrine—ADRA2B—Hemostasis—VEGFA—brain cancer	0.0001	0.000223	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—SMO—brain cancer	9.96e-05	0.000222	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—PTCH1—brain cancer	9.96e-05	0.000222	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—VAV1—brain cancer	9.91e-05	0.000221	CbGpPWpGaD
Norepinephrine—ADRA2C—GPCR downstream signaling—PIK3CG—brain cancer	9.9e-05	0.000221	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—TRPC6—brain cancer	9.76e-05	0.000217	CbGpPWpGaD
Norepinephrine—ADRA1B—GPCR downstream signaling—PIK3CG—brain cancer	9.74e-05	0.000217	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling by GPCR—PIK3CG—brain cancer	9.71e-05	0.000216	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—PIK3CG—brain cancer	9.66e-05	0.000215	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—APC—brain cancer	9.66e-05	0.000215	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—PIK3CG—brain cancer	9.62e-05	0.000214	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—SMO—brain cancer	9.59e-05	0.000214	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—PTCH1—brain cancer	9.59e-05	0.000214	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—PIK3CG—brain cancer	9.5e-05	0.000212	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—NOTCH2—brain cancer	9.48e-05	0.000211	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—SHH—brain cancer	9.4e-05	0.000209	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—NOTCH2—brain cancer	9.39e-05	0.000209	CbGpPWpGaD
Norepinephrine—ADRA2C—Hemostasis—VEGFA—brain cancer	9.37e-05	0.000209	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—NOTCH2—brain cancer	9.27e-05	0.000207	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—BSG—brain cancer	9.13e-05	0.000203	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—TRPC6—brain cancer	9.06e-05	0.000202	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—VAV1—brain cancer	9.03e-05	0.000201	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—PIK3CG—brain cancer	8.99e-05	0.0002	CbGpPWpGaD
Norepinephrine—DRD2—GPCR downstream signaling—PIK3CG—brain cancer	8.98e-05	0.0002	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—VAV1—brain cancer	8.95e-05	0.000199	CbGpPWpGaD
Norepinephrine—ADRA2A—Hemostasis—IL2—brain cancer	8.95e-05	0.000199	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—SMO—brain cancer	8.91e-05	0.000199	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—PTCH1—brain cancer	8.91e-05	0.000199	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—PIK3CG—brain cancer	8.85e-05	0.000197	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—VAV1—brain cancer	8.84e-05	0.000197	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling by GPCR—EGFR—brain cancer	8.81e-05	0.000196	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—NOTCH2—brain cancer	8.77e-05	0.000195	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCR downstream signaling—PIK3CG—brain cancer	8.65e-05	0.000193	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—NOTCH2—brain cancer	8.63e-05	0.000192	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—HES1—brain cancer	8.53e-05	0.00019	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—VAV1—brain cancer	8.36e-05	0.000186	CbGpPWpGaD
Norepinephrine—ADRA1D—GPCR downstream signaling—IL2—brain cancer	8.26e-05	0.000184	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—VAV1—brain cancer	8.23e-05	0.000183	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—PIK3CG—brain cancer	8.15e-05	0.000182	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—PDGFRA—brain cancer	8.12e-05	0.000181	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR downstream signaling—PIK3CG—brain cancer	8.04e-05	0.000179	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—NOTCH2—brain cancer	7.96e-05	0.000177	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—SPP1—brain cancer	7.88e-05	0.000176	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—PIK3CG—brain cancer	7.86e-05	0.000175	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—IDH1—brain cancer	7.85e-05	0.000175	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—HES1—brain cancer	7.77e-05	0.000173	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—HES1—brain cancer	7.7e-05	0.000172	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—NOTCH2—brain cancer	7.67e-05	0.000171	CbGpPWpGaD
Norepinephrine—ADRA2A—Hemostasis—VEGFA—brain cancer	7.61e-05	0.00017	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—HES1—brain cancer	7.6e-05	0.000169	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—VAV1—brain cancer	7.59e-05	0.000169	CbGpPWpGaD
Norepinephrine—ADRA2B—Hemostasis—TP53—brain cancer	7.58e-05	0.000169	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—RELA—brain cancer	7.55e-05	0.000168	CbGpPWpGaD
Norepinephrine—ADRB1—GPCR downstream signaling—IL2—brain cancer	7.52e-05	0.000168	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—ERBB2—brain cancer	7.5e-05	0.000167	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling by GPCR—IL2—brain cancer	7.5e-05	0.000167	CbGpPWpGaD
Norepinephrine—ADRA2B—GPCR downstream signaling—IL2—brain cancer	7.46e-05	0.000166	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—PDGFRA—brain cancer	7.4e-05	0.000165	CbGpPWpGaD
Norepinephrine—ADRB2—GPCR downstream signaling—IL2—brain cancer	7.36e-05	0.000164	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—PDGFRA—brain cancer	7.33e-05	0.000163	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—VAV1—brain cancer	7.31e-05	0.000163	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—PIK3CG—brain cancer	7.3e-05	0.000163	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—PDGFRA—brain cancer	7.24e-05	0.000161	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—HES1—brain cancer	7.19e-05	0.00016	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—SPP1—brain cancer	7.18e-05	0.00016	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—IRS2—brain cancer	7.13e-05	0.000159	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—NOTCH2—brain cancer	7.12e-05	0.000159	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—SPP1—brain cancer	7.12e-05	0.000159	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—HES1—brain cancer	7.08e-05	0.000158	CbGpPWpGaD
Norepinephrine—ADRA2C—Hemostasis—TP53—brain cancer	7.08e-05	0.000158	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—SPP1—brain cancer	7.03e-05	0.000157	CbGpPWpGaD
Norepinephrine—ADRA2C—GPCR downstream signaling—IL2—brain cancer	6.96e-05	0.000155	CbGpPWpGaD
Norepinephrine—ADRA1B—GPCR downstream signaling—IL2—brain cancer	6.85e-05	0.000153	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—PDGFRA—brain cancer	6.85e-05	0.000153	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling by GPCR—IL2—brain cancer	6.83e-05	0.000152	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—IL2—brain cancer	6.8e-05	0.000152	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—VAV1—brain cancer	6.79e-05	0.000151	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—IL2—brain cancer	6.77e-05	0.000151	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—PDGFRA—brain cancer	6.74e-05	0.00015	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—IL2—brain cancer	6.68e-05	0.000149	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—SPP1—brain cancer	6.65e-05	0.000148	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—CCND1—brain cancer	6.63e-05	0.000148	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—CTNNB1—brain cancer	6.57e-05	0.000146	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—SPP1—brain cancer	6.54e-05	0.000146	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—PIK3CG—brain cancer	6.53e-05	0.000145	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—HES1—brain cancer	6.53e-05	0.000145	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—IRS2—brain cancer	6.49e-05	0.000145	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—IRS2—brain cancer	6.44e-05	0.000143	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	6.39e-05	0.000142	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—IRS2—brain cancer	6.35e-05	0.000142	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—PIK3CG—brain cancer	6.35e-05	0.000141	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—IL2—brain cancer	6.32e-05	0.000141	CbGpPWpGaD
Norepinephrine—DRD2—GPCR downstream signaling—IL2—brain cancer	6.32e-05	0.000141	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—APC—brain cancer	6.3e-05	0.00014	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—PIK3CG—brain cancer	6.3e-05	0.00014	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—HES1—brain cancer	6.29e-05	0.00014	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—IL2—brain cancer	6.22e-05	0.000139	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—PDGFRA—brain cancer	6.21e-05	0.000138	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—ENO2—brain cancer	6.21e-05	0.000138	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCR downstream signaling—IL2—brain cancer	6.09e-05	0.000136	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—PIK3CG—brain cancer	6.08e-05	0.000136	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—SPP1—brain cancer	6.03e-05	0.000134	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—IRS2—brain cancer	6.01e-05	0.000134	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—PDGFRA—brain cancer	5.99e-05	0.000133	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—IRS2—brain cancer	5.92e-05	0.000132	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—HES1—brain cancer	5.84e-05	0.00013	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—SPP1—brain cancer	5.81e-05	0.000129	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—VEGFA—brain cancer	5.78e-05	0.000129	CbGpPWpGaD
Norepinephrine—ADRA2A—Hemostasis—TP53—brain cancer	5.75e-05	0.000128	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—IL2—brain cancer	5.74e-05	0.000128	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—PIK3CG—brain cancer	5.74e-05	0.000128	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—APC—brain cancer	5.74e-05	0.000128	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling by GPCR—EGFR—brain cancer	5.74e-05	0.000128	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—STAT3—brain cancer	5.72e-05	0.000128	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—APC—brain cancer	5.68e-05	0.000127	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—PIK3CG—brain cancer	5.68e-05	0.000127	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR downstream signaling—IL2—brain cancer	5.66e-05	0.000126	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—APC—brain cancer	5.61e-05	0.000125	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—PIK3CG—brain cancer	5.61e-05	0.000125	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—PDGFRA—brain cancer	5.56e-05	0.000124	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—IL2—brain cancer	5.53e-05	0.000123	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—IRS2—brain cancer	5.45e-05	0.000122	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—SPP1—brain cancer	5.4e-05	0.00012	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—MYC—brain cancer	5.32e-05	0.000119	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—APC—brain cancer	5.31e-05	0.000118	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—PIK3CG—brain cancer	5.31e-05	0.000118	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—IRS2—brain cancer	5.26e-05	0.000117	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling by GPCR—EGFR—brain cancer	5.23e-05	0.000116	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—APC—brain cancer	5.23e-05	0.000116	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—PIK3CG—brain cancer	5.23e-05	0.000116	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—EGFR—brain cancer	5.2e-05	0.000116	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—EGFR—brain cancer	5.18e-05	0.000115	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—PIK3CG—brain cancer	5.16e-05	0.000115	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—IL2—brain cancer	5.14e-05	0.000114	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—EGFR—brain cancer	5.11e-05	0.000114	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—RELA—brain cancer	4.92e-05	0.00011	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—ERBB2—brain cancer	4.89e-05	0.000109	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—IRS2—brain cancer	4.88e-05	0.000109	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—EGFR—brain cancer	4.84e-05	0.000108	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—PIK3CG—brain cancer	4.82e-05	0.000107	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—APC—brain cancer	4.82e-05	0.000107	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—EGFR—brain cancer	4.76e-05	0.000106	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—APC—brain cancer	4.64e-05	0.000103	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—PIK3CG—brain cancer	4.64e-05	0.000103	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—RELA—brain cancer	4.48e-05	9.99e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—ERBB2—brain cancer	4.45e-05	9.93e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—RELA—brain cancer	4.44e-05	9.9e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—IL2—brain cancer	4.43e-05	9.87e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—ERBB2—brain cancer	4.41e-05	9.83e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—EGFR—brain cancer	4.39e-05	9.78e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—RELA—brain cancer	4.38e-05	9.77e-05	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—TP53—brain cancer	4.37e-05	9.73e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—ERBB2—brain cancer	4.36e-05	9.71e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—CCND1—brain cancer	4.32e-05	9.62e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—PIK3CG—brain cancer	4.31e-05	9.61e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—APC—brain cancer	4.31e-05	9.61e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—CTNNB1—brain cancer	4.28e-05	9.53e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—EGFR—brain cancer	4.23e-05	9.42e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—RELA—brain cancer	4.15e-05	9.24e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—ERBB2—brain cancer	4.12e-05	9.19e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—RELA—brain cancer	4.08e-05	9.1e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—ERBB2—brain cancer	4.06e-05	9.04e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—IL2—brain cancer	4.04e-05	9e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—IL2—brain cancer	4e-05	8.91e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—IL2—brain cancer	3.95e-05	8.8e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—CCND1—brain cancer	3.94e-05	8.77e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—EGFR—brain cancer	3.93e-05	8.76e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—CCND1—brain cancer	3.9e-05	8.69e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—CTNNB1—brain cancer	3.9e-05	8.68e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—CTNNB1—brain cancer	3.86e-05	8.6e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—CCND1—brain cancer	3.85e-05	8.58e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—CTNNB1—brain cancer	3.81e-05	8.49e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—VEGFA—brain cancer	3.77e-05	8.39e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—RELA—brain cancer	3.76e-05	8.39e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—ERBB2—brain cancer	3.74e-05	8.34e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—IL2—brain cancer	3.74e-05	8.33e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—STAT3—brain cancer	3.73e-05	8.31e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—IL2—brain cancer	3.68e-05	8.19e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—CCND1—brain cancer	3.64e-05	8.12e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—RELA—brain cancer	3.63e-05	8.08e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—CTNNB1—brain cancer	3.61e-05	8.04e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—ERBB2—brain cancer	3.6e-05	8.03e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—CCND1—brain cancer	3.58e-05	7.99e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—CTNNB1—brain cancer	3.55e-05	7.91e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—MYC—brain cancer	3.46e-05	7.72e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—VEGFA—brain cancer	3.43e-05	7.64e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—VEGFA—brain cancer	3.4e-05	7.58e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—STAT3—brain cancer	3.4e-05	7.57e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—IL2—brain cancer	3.39e-05	7.55e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—EGFR—brain cancer	3.39e-05	7.55e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—RELA—brain cancer	3.37e-05	7.51e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—STAT3—brain cancer	3.37e-05	7.5e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—VEGFA—brain cancer	3.36e-05	7.48e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—ERBB2—brain cancer	3.35e-05	7.46e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—STAT3—brain cancer	3.32e-05	7.4e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CCND1—brain cancer	3.3e-05	7.36e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CTNNB1—brain cancer	3.27e-05	7.29e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—IL2—brain cancer	3.27e-05	7.28e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CCND1—brain cancer	3.18e-05	7.1e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—VEGFA—brain cancer	3.18e-05	7.08e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—MYC—brain cancer	3.16e-05	7.03e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CTNNB1—brain cancer	3.15e-05	7.03e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—STAT3—brain cancer	3.14e-05	7.01e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—MYC—brain cancer	3.13e-05	6.97e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—VEGFA—brain cancer	3.12e-05	6.96e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—STAT3—brain cancer	3.09e-05	6.9e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—MYC—brain cancer	3.09e-05	6.88e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—EGFR—brain cancer	3.09e-05	6.88e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—EGFR—brain cancer	3.06e-05	6.82e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—IL2—brain cancer	3.03e-05	6.76e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—EGFR—brain cancer	3.02e-05	6.73e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CCND1—brain cancer	2.96e-05	6.59e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CTNNB1—brain cancer	2.93e-05	6.53e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—MYC—brain cancer	2.92e-05	6.51e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—VEGFA—brain cancer	2.88e-05	6.42e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—MYC—brain cancer	2.88e-05	6.41e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—EGFR—brain cancer	2.86e-05	6.37e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—STAT3—brain cancer	2.85e-05	6.36e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—PIK3CG—brain cancer	2.85e-05	6.34e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—TP53—brain cancer	2.84e-05	6.34e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—EGFR—brain cancer	2.81e-05	6.27e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—VEGFA—brain cancer	2.78e-05	6.19e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—STAT3—brain cancer	2.75e-05	6.12e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—MYC—brain cancer	2.65e-05	5.91e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—EGFR—brain cancer	2.59e-05	5.78e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—TP53—brain cancer	2.59e-05	5.78e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—VEGFA—brain cancer	2.58e-05	5.75e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—TP53—brain cancer	2.57e-05	5.72e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—MYC—brain cancer	2.55e-05	5.69e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—STAT3—brain cancer	2.55e-05	5.69e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—TP53—brain cancer	2.54e-05	5.65e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—EGFR—brain cancer	2.5e-05	5.57e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—TP53—brain cancer	2.4e-05	5.35e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—MYC—brain cancer	2.37e-05	5.29e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—TP53—brain cancer	2.36e-05	5.26e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—EGFR—brain cancer	2.32e-05	5.17e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—TP53—brain cancer	2.18e-05	4.85e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—TP53—brain cancer	2.1e-05	4.67e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—TP53—brain cancer	1.95e-05	4.34e-05	CbGpPWpGaD
